| P50 | author | Hans Klein | Q70663021 |
| | Ulrich Eisel | Q40741711 |
| P2093 | author name string | M Peters | |
| | E M van Buel | |
| | F J Bosker | |
| | K Patas | |
| P2860 | cites work | Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile | Q21245293 |
| | Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. | Q50610700 |
| | Real and artificial immune systems: computing the state of the body. | Q51626392 |
| | Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 |
| | A controlled study of cellular immune function in affective disorders before and during somatic therapy | Q61480130 |
| | Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 |
| | Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression | Q74588178 |
| | Effect of electroconvulsive therapy on hematological parameters | Q77307963 |
| | Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy | Q79347499 |
| | Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor | Q80783829 |
| | Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder | Q80988997 |
| | Reduction of Iba1-expressing microglial process density in the hippocampus following electroconvulsive shock | Q81420007 |
| | Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression | Q84840663 |
| | BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide | Q48281695 |
| | Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study | Q48289563 |
| | Transport of brain-derived neurotrophic factor across the blood-brain barrier | Q48307102 |
| | Modulation of non-specific immunity by hippocampal stimulation | Q48339547 |
| | Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. | Q48385750 |
| | The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression | Q48400014 |
| | Activation of extracellular signal-regulated kinase signaling by chronic electroconvulsive shock in the rat frontal cortex | Q48401571 |
| | Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats | Q48403654 |
| | Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells | Q48408197 |
| | Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features | Q48411902 |
| | Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs. | Q48469586 |
| | Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only | Q48486630 |
| | Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications | Q48507006 |
| | Glial cell activation in response to electroconvulsive seizures | Q48562124 |
| | Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages | Q48569546 |
| | A study of brain and serum brain-derived neurotrophic factor protein in Wistar and Wistar-Kyoto rat strains after electroconvulsive stimulus | Q48594718 |
| | Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. | Q48635095 |
| | Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy | Q48739906 |
| | Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. | Q48871364 |
| | A role for brain-derived neurotrophic factor in B cell development | Q48892241 |
| | Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. | Q48911884 |
| | Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder | Q48942939 |
| | Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes | Q49049474 |
| | Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans | Q24627318 |
| | From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 |
| | How do immune cells support and shape the brain in health, disease, and aging? | Q26995364 |
| | Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior | Q27694728 |
| | Neurotrophins and the immune system | Q28191216 |
| | Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 |
| | VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants | Q28579192 |
| | Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 |
| | A neurotrophic model for stress-related mood disorders | Q29616291 |
| | A meta-analysis of cytokines in major depression | Q29617325 |
| | Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression | Q29617326 |
| | Vascular niche for adult hippocampal neurogenesis | Q29619395 |
| | Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 |
| | Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models | Q30497021 |
| | Monoamine neurocircuitry in depression and strategies for new treatments | Q30619239 |
| | Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway | Q33543136 |
| | Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users | Q33620656 |
| | Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis | Q33964983 |
| | The corticosteroid receptor hypothesis of depression | Q34057906 |
| | Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression | Q34084772 |
| | Course of illness, hippocampal function, and hippocampal volume in major depression | Q34331120 |
| | The neurotrophic factors in non-neuronal tissues | Q34350928 |
| | The relationship of depression and stressors to immunological assays: a meta-analytic review | Q34375707 |
| | Multi-session transcranial direct current stimulation (tDCS) elicits inflammatory and regenerative processes in the rat brain | Q34396003 |
| | Molecular and cellular actions of chronic electroconvulsive seizures. | Q34475270 |
| | Pathophysiology of depression: the concept of synaptic plasticity | Q34548351 |
| | Using ECT in schizophrenia: a review from a clinical perspective | Q34628445 |
| | Reversible modulations of neuronal plasticity by VEGF. | Q34720857 |
| | Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study | Q34769083 |
| | The current state of the neurogenic theory of depression and anxiety | Q34943860 |
| | Disturbance of the glutamatergic system in mood disorders | Q35149888 |
| | Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte. | Q35181128 |
| | Adult hippocampal neurogenesis buffers stress responses and depressive behaviour | Q35182020 |
| | Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. | Q35618371 |
| | Is depression an inflammatory disorder? | Q35774501 |
| | Association of depressive disorders, depression characteristics and antidepressant medication with inflammation | Q35844355 |
| | Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis | Q46212071 |
| | Effect of repeated administration of paroxetine and electroconvulsive shock on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats | Q46500098 |
| | Chronic treatment with electroconvulsive shock may modulate the immune function of macrophages | Q46518539 |
| | Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. | Q46575293 |
| | Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures | Q46907526 |
| | Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. | Q47351035 |
| | Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients | Q47839802 |
| | Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients | Q47947818 |
| | Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus | Q48109931 |
| | Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. | Q48180704 |
| | Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. | Q48181396 |
| | Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression | Q48188547 |
| | Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. | Q48196575 |
| | Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients | Q48210559 |
| | Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects | Q48273312 |
| | Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor | Q36099395 |
| | Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. | Q36539999 |
| | Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus | Q36837563 |
| | The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior | Q36925139 |
| | Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study | Q37208545 |
| | Adult hippocampal neurogenesis and related neurotrophic factors | Q37496151 |
| | Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders. | Q37519529 |
| | Microglia: biology and pathology | Q37655575 |
| | Antidepressant Pharmacotherapy Failure and Response to Subsequent Electroconvulsive Therapy | Q37784983 |
| | Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies? | Q37899578 |
| | Progress in defining the biological causes of schizophrenia | Q37906804 |
| | Adult neurogenesis in Parkinson's disease | Q38024276 |
| | The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia | Q38057548 |
| | The role of inflammation in sporadic and familial Parkinson's disease | Q38105903 |
| | The role of the immune system in Huntington's disease | Q38129870 |
| | Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). | Q38130092 |
| | The role of ECT in suicide prevention | Q38148994 |
| | The role of microglial activation in disease progression | Q38210510 |
| | Positive feedback loop of autocrine BDNF from microglia causes prolonged microglia activation | Q38961726 |
| | Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease | Q39282122 |
| | Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression | Q39532426 |
| | Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury | Q40037292 |
| | Cost of depression in Europe | Q40284204 |
| | Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients | Q40318595 |
| | Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain | Q40694827 |
| | Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. | Q40869638 |
| | Region specific hypothalamic neuronal activation and endothelial cell proliferation in response to electroconvulsive seizures | Q42491325 |
| | Repeated electroconvulsive seizures increase the number of vessel-associated macrophages in rat hippocampus | Q42510798 |
| | Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat | Q42870379 |
| | Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? | Q42943930 |
| | Neurotrophic factors in serum following ECT: a pilot study | Q43239656 |
| | Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. | Q43260112 |
| | ECT for Parkinson's disease | Q43297364 |
| | Immune changes induced by electroconvulsive therapy (ECT). | Q43684685 |
| | Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain | Q44598165 |
| | Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat hippocampus | Q44660825 |
| | Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma | Q44669549 |
| | Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala | Q44801148 |
| | Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex | Q45071445 |
| | ECT in genetically confirmed Huntington's disease | Q45293979 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | peptide | Q172847 |
| | nerve tissue protein | Q6996861 |
| | major depressive disorder | Q42844 |
| | nerve growth factors | Q98072643 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e609 | |
| P577 | publication date | 2015-07-28 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all? | |
| P478 | volume | 5 | |